The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 760K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for SP Andrews


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
8
Biophysical mapping of the adenosine A2A receptor.EBI
Heptares Therapeutics
16
Identification of novel adenosine A(2A) receptor antagonists by virtual screening.EBI
Heptares Therapeutics
12
Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.EBI
Heptares Therapeutics
5
The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K).EBI
University of Cambridge
1
The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool Molecules.EBI
University of Cambridge
6
Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor.EBI
University of Cambridge
1
Small Molecule CXCR3 Antagonists.EBI
Heptares Therapeutics
40
Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding Mode.EBI
University of Cambridge
43
Compositions and methods for inhibiting kinasesBDB
Inhibikase Therapeutics
8
FXR (NR1H4) modulating compoundsBDB
Gilead Sciences